Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error at the study URL, replacing the expected study record content. This indicates an access restriction preventing users from viewing the study details.SummaryDifference18%

- Check54 days agoChange DetectedThe page now lists 2018 ( U.S. NIH Grant/Contract ) as part of the study identifiers, and the revision history shows an update to version 3.6.6, replacing the previous 3.6.5 entry.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new build of the page. This appears to be a technical release update rather than a modification to the trial information.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a small platform update.SummaryDifference0.1%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.